This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Abstract
The objective of this study was to replicate findings from an earlier study by Stern et al. of an increased risk of mortality in Alzheimer's disease (AD) patients with higher levels of education and to compare this risk with the risk of death in the elderly population. As part of a community-based follow-up study on dementia (Amsterdam Study of the Elderly[AMSTEL]) a cohort of 4,051 noninstitutionalized elderly age 65 to 84 years stratified in four 5-year strata of equal size was screened for dementia using the MMSE (Mini-Mental State Examination). Those suspected of dementia received diagnostic evaluation using the CAMDEX (Cambridge examination for mental disorders in the elderly). Clinical diagnoses of probable AD were made according to NINCDS-ADRDA criteria. Thirty-six prevalent patients were diagnosed as having AD. The suspected subcohort was followed up yearly over a period of 4 years. During the three yearly follow-ups, 30 incident patients received a diagnosis as well. After 6 years mortality data were obtained from municipality records. Cox proportional hazards models adjusted for age and sex were used to estimate the relative risk of death associated with the level of education. Relative risk of death decreased (although not statistically significant) in AD patients as level of education increased (RR= 0.86; 95% CI, 0.63 to 1.19). In the full baseline sample, relative risk of death decreased as level of education increased (RR = 0.86; 95% CI, 0.89 to 0.97). In this study we could not replicate the findings of Stern et al. of an increased risk of death in more highly educated AD patients. Several major differences between the two studies, among which difference in populations used is considered to be most important, are discussed that might explain the conflicting results. We conclude that higher education is not associated with increased risk of mortality in AD patients.
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
